NCT01401374

Brief Summary

The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,258

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 25, 2011

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

April 10, 2017

Status Verified

April 1, 2017

Enrollment Period

5 years

First QC Date

July 21, 2011

Last Update Submit

April 7, 2017

Conditions

Vitiligo Vulgaris

Keywords

Vitiligo VulgarisAutoimmunityThyroid Disease

Outcome Measures

Primary Outcomes (1)

  • Correlation of Disease State in Vitiligo with Clinical and Psychological Measures

    Self-reported retrospective single survey

Study Arms (2)

Vitiligo Patients

patients with vitiligo vulgaris

Controls

Individuals without vitiligo vulgaris

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals self-reporting vitiligo vulgaris and controls who do not have vitiligo vulgaris

You may qualify if:

  • Ability to complete survey

You may not qualify if:

  • Inability to complete survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Luke's-Roosevelt Hospital Center

New York, New York, 10025, United States

Location

Related Publications (3)

  • Silverberg JI, Reja M, Silverberg NB. Regional variation of and association of US birthplace with vitiligo extent. JAMA Dermatol. 2014 Dec;150(12):1298-305. doi: 10.1001/jamadermatol.2014.899.

    PMID: 25006795DERIVED

  • Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014 May-Jun;31(3):309-18. doi: 10.1111/pde.12226. Epub 2013 Oct 18.

    PMID: 24304125DERIVED

  • Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013 Feb;149(2):159-64. doi: 10.1001/jamadermatol.2013.927.

    PMID: 23560296DERIVED

MeSH Terms

Conditions

VitiligoAutoimmune DiseasesThyroid Diseases

Condition Hierarchy (Ancestors)

HypopigmentationPigmentation DisordersSkin DiseasesSkin and Connective Tissue DiseasesImmune System DiseasesEndocrine System Diseases

Study Officials

  • Nanette Silverberg, MD

    St. Luke's-Roosevelt Hospital Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2011

First Posted

July 25, 2011

Study Start

March 1, 2011

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

April 10, 2017

Record last verified: 2017-04

Locations

US(1)